Key result
Discharge anticoagulation is linked to increased postdischarge bleeding requiring rehospitalization, seen in ~2.6% of patients.
Why the study?
Does anticoagulation at discharge increase the risk of clinically relevant bleeding requiring rehospitalization in patients discharged from a medical hospitalization?
Cohort
Does anticoagulation at discharge increase the risk of clinically relevant bleeding requiring rehospitalization in patients discharged from a medical hospitalization?
Clinically relevant bleeding requiring rehospitalization occurs in 2.6% of medical hospitalizations, with anticoagulation at discharge identified as a significant risk factor.
BACKGROUND: Clinically relevant bleeding after discharge from a medical hospitalization is associated with increased morbidity and mortality. There is limited knowledge of the risk factors for this bleeding. OBJECTIVES: We aimed to determine the risk factors for bleeding leading to rehospitalization after hospital discharge. METHODS: The study population consisted of primary care patients followed longitudinally from October 2010 to September 2019 for medical hospitalization and clinically relevant bleeding. People discharged alive from a medical hospitalization were followed for up to 90 days for postdischarge bleeding requiring rehospitalization. Age-, sex- (male vs female), and length of stay-adjusted hazard ratios for candidate bleeding risk factors were estimated using Cox proportional hazards models. CONCLUSION: Postdischarge bleeding requiring hospitalization occurs in 2.6% of medical hospitalizations and has objective and readily identifiable risk factors. Findings suggest that clinically relevant bleeding postdischarge may be predictable and quantifiable, which could help increase the safety of anticoagulation decisions at discharge.
No takes yet. Share an insight, caveat, or question.
Gergi et al. (2025) conducted a cohort in Medical hospitalization. Anticoagulation at discharge was evaluated on Postdischarge bleeding requiring rehospitalization. Anticoagulation at discharge was associated with an increased risk for clinically relevant bleeding postdischarge, which occurred overall in 2.6% of medical hospitalizations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: